Sharon's Tack Shack is categorized under Proprietary (Patent) Medicines, Nec in Collinsville, IL and active since 2003.
Sharon's Tack Shack was established in 2003, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Proprietary (Patent) Medicines, Nec business, which does work in the B2B market, and is classified as a Proprietary (Patent) Medicines, Nec, under code number 3391120 by the NAICS.
If you are seeking more information, feel free to contact Sharon Morgan at the company’s single location by writing to 9301 Collinsville Road, Collinsville, Illinois IL 62234 or by phoning (618) 345-8660. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sharon's Tack Shack |
| Contact Person: | Sharon Morgan |
| Address: | 9301 Collinsville Road, Collinsville, Illinois 62234 |
| Phone Number: | (618) 345-8660 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Proprietary (Patent) Medicines, Nec |
| SIC Code: | 5122 |
| NAICS Code: | 3391120 |
| Share This Business: |
Sharon's Tack Shack was started in 2003 to provide professional Proprietary (Patent) Medicines, Nec under the SIC code 5122 and NAICS code 3391120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Sharon Morgan for inquiries that concern Sharon's Tack Shack by calling the company number (618) 345-8660, as your correspondence is most welcome. Additionally, the physical location of the single location of Sharon's Tack Shack can be found at the coordinates 38.65965,-90.0371 as well as the street address 9301 Collinsville Road in Collinsville, Illinois 62234.
For its online presence, you may visit Sharon's Tack Shack’s website at and engage with its social media outlets through on Twitter and on Facebook.